Bristol-Myers, Gilead rise, SVB Financial, BioMarin fall
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:
Bristol-Myers Squibb Co., up $2.20 to $72.36.
The pharmaceutical company received U.S. approval for a psoriasis treatment.
Gilead Sciences Inc., up $2.73 to $68.01.
The drug developer announced agreements to settle patent disputes over HIV treatments.
Yum Brands Inc., up $1.17 to $117.26.
The owner of KFC and Taco Bell announced a new $2 billion stock buyback plan.
SVB Financial Group, down $16.82 to $406.15.
Investors were disappointed by the bank’s latest update to its financial forecast.
BioMarin Pharmaceutical Inc., down $2.69 to $90.24.
The drug developer gave investors a potentially discouraging update on the development of a hemophilia drug.
Chevron Corp., up $2.53 to $162.50 Energy companies gained ground along with rising U.S. crude oil prices.
Newmont Corp., up 78 cents to $43.95.
The gold producer gained ground as prices for the precious metal edged higher.
Stellantis NV, up 52 cents to $13.93.
United Auto Workers on strike at the carmaker’s casting plant in Indiana have reached a tentative deal.